Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3Genitourinary 2Breast 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Other 1Endocrine 1Classical hematology 1

Conditions

Mucositis 1Esophagitis 1

Interventions

Radiotherapy 9naloxegol 7Metformin 7Surveys and Questionnaires 6Cisplatin 6Exenatide 4Vitamin D 3Sugars 3Fibroblast Growth Factor 7 3Water 2Therapeutics 2Testosterone 2Resistance Training 2Radiation 2Nutrition Assessment 2Methods 2Low-Level Light Therapy 2Injections 2Fentanyl 2Drug Therapy 2Dexamethasone 2Cryotherapy 2Calcium Dobesilate 2Anastrozole 2prucalopride 1peppermint oil 1penclomedine 1pegfilgrastim 1oxycodone-acetaminophen 1methylnaltrexone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Glutamine × Other × Clear all
NCT01952847 2022-06-15

Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis

M.D. Anderson Cancer Center

Phase 3 Terminated
77 enrolled 28 charts
Other

Esophagitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡